preprint
S6K1 (ribosomal protein S6 kinase beta-1) is a serine/threonine kinase integral to regulating protein synthesis, gene expression, and metabolic homeostasis. Its structural complexity, including multiple isoforms and a unique kinase domain, enables diverse functions across cellular contexts. This review examines the intricate structure of S6K1, its tissue-specific expression, and subcellular localization, emphasizing distinct roles in cellular processes. Beyond transcriptional control, S6K1 activity and stability are critically influenced by post-translational modifications like phosphorylation and acetylation. S6K1’s physiological roles span cell growth, immune responses, and muscle hypertrophy, while its dysregulation is linked to cancer, cardiovascular diseases, metabolic disorders, and neurodegeneration. In neurodegenerative diseases, altered S6K1 activity, particularly its phosphorylation, is associated with reduced neuronal viability, contributing to conditions like Parkinson’s. This manuscript synthesizes current knowledge on S6K1, highlighting its therapeutic potential across various diseases.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.22541/au.172501394.49993134/v1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.